Claude Opus 4.6: Anthropic’s powerful model for coding, agents, and enterprise workflows is now available in Microsoft Foundry

By Dustin Ward

At Microsoft we believe that intelligence and trust are the core requirements of agentic AI at scale. Built on Azure, Microsoft Foundry brings these capabilities together on a secure, scalable cloud foundation for enterprise AI. Today, with the launch of Claude Opus 4.6 in Microsoft Foundry, we bring even more capability to agents that increasingly learn…

PostgreSQL on Azure supercharged for AI

By Dustin Ward

We are almost a century removed from when a group of computer scientists at Dartmouth College coined the term “Artificial Intelligence.” In the 75-year span, AI has become common vernacular, making inroads from imagined to mainstream. Today, we see entire industries being disrupted and entire ecosystems revolutionized by AI. To keep up, the way developers…

Maia 200: The AI accelerator built for inference

By Dustin Ward

Today, we’re proud to introduce Maia 200, a breakthrough inference accelerator engineered to dramatically improve the economics of AI token generation. Maia 200 is an AI inference powerhouse: an accelerator built on TSMC’s 3nm process with native FP8/FP4 tensor cores, a redesigned memory system with 216GB HBM3e at 7 TB/s and 272MB of on-chip SRAM,…

Chart your AI and agent strategy with Microsoft Marketplace

By Dustin Ward

A new category of organization is emerging that embeds AI across every layer of their operations—accelerating delivery, scaling efficiently, and unlocking new business potential. These companies are leading Frontier Firm transformation, not simply adopting AI but rebuilding around it to set the pace for the next decade of innovation. Successfully adopting AI requires choosing the…

Bridging the gap between AI and medicine: Claude in Microsoft Foundry advances capabilities for healthcare and life sciences customers

By Dustin Ward

Healthcare and life sciences organizations are navigating an era of unprecedented complexity. Administrative burden continues to rise, clinical workflows remain fragmented, and scientific discovery is advancing faster than traditional systems can support. At the same time, trust, safety, and regulatory compliance remain non-negotiable. From clearing prior authorization backlogs to accelerating clinical research and regulatory submissions,…